353
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder

ORCID Icon & ORCID Icon
Pages 27-33 | Received 02 Nov 2022, Accepted 14 Dec 2022, Published online: 10 Jan 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.